Eli Lilly and Company

Scientific Advisor, Target Discovery and External Innovation Laison – Lilly Gene Therapy

United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess an advanced degree, such as a Ph.D., in a relevant scientific field, and demonstrate in-depth scientific understanding of gene therapy basics. Strong verbal and written communication skills are essential, along with the ability to provide succinct updates to internal management and governance teams and external partnership governance meetings. A collaborative mindset and ability to build positive relationships without authority are also critical, as is the capacity for effective cross-functional collaboration to support experimental design, data interpretation, and strategic decision-making.

Responsibilities

The Scientific Advisor will coordinate activities and relationships related to external innovation, collaborating with internal groups like CMC, Research, and Bioanalytics. They will partner with Gene Therapy leadership to support data-driven decision-making and the design of experiments, documenting execution strategies and timelines. Furthermore, the role involves partnering with Business Development and Alliance Management teams on due diligence, evaluating agreements, and setting up meeting updates, executing documentation of governance meetings, and ensuring alignment with organizational priorities.

Skills

Gene Therapy
CNS Delivery
Inner Ear Therapeutics
Scientific Communication
External Innovation
Alliance Management
Data Interpretation
Experimental Design
Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI